Site US10021 — Bethlehem, Pennsylvania

Site US10021 is a clinical research site located in Bethlehem, Pennsylvania, United States 18015.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US10021 has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC).

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bethlehem

Browse all research sites in Pennsylvania · View every site in Bethlehem

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10021?

Site US10021 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10021 conducted?

Site US10021 has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer (NSCLC).

Is Site US10021 accredited by Crixeo Clinical Trials?

Site US10021 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10021?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.